Plain-English translation of NCT06907602 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing different combinations of and immunotherapy—sometimes with added radiation—given before surgery for advanced esophageal cancer. Doctors have found that combining with immunotherapy works better than alone, but they're still figuring out the best number of treatment cycles and whether adding radiation therapy helps even more.
While this treatment approach has shown promise, doctors want to know the optimal way to give it: should patients receive 2 cycles or 4 cycles before surgery? And for patients whose tumors don't shrink as much as hoped, could adding radiation therapy improve the chances of destroying the cancer completely?
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either 2 cycles of plus immunotherapy, 4 cycles of plus immunotherapy, or 4 cycles of plus immunotherapy combined with radiation therapy. All groups will then have surgery to remove the tumor. You'll have regular clinic visits for imaging scans, blood tests, and check-ups during the treatment phase, which lasts several weeks to months depending on your assigned group.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China